EFFECT ON THE ENDOCRINE SYSTEM OF A NEW DOPAMINERGIC AGENT, IBOPAMINE

被引:7
作者
SORETH, JT
DUBB, JW
ALLISON, NL
ALEXANDER, F
BODEN, G
STOTE, RM
机构
[1] TEMPLE UNIV HOSP,PHILADELPHIA,PA 19140
[2] SK&F LABS,PHILADELPHIA,PA 19101
关键词
D O I
10.1038/clpt.1987.86
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:627 / 632
页数:6
相关论文
共 23 条
[1]   ADRENERGIC CONTROL OF SOMATOSTATIN RELEASE [J].
BODEN, G ;
MASTER, RW ;
SATTLER, MA ;
MARTIN, JS ;
TANSY, MF ;
OWEN, OE .
ENDOCRINOLOGY, 1982, 111 (04) :1166-1172
[2]   NON-INVASIVE EVALUATION OF THE EFFECTS OF ORAL IBOPAMINE (SB-7505) ON CARDIAC AND RENAL-FUNCTION IN PATIENTS WITH CONGESTIVE HEART-FAILURE [J].
CAS, LD ;
MANCA, C ;
BERNARDINI, B ;
VASINI, G ;
VISIOLI, O .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1982, 4 (03) :436-440
[3]  
CAS LD, 1983, J CARDIOVASC PHARM, V5, P249
[4]  
Faloona G.R, 1974, METHOD HORM RADIOIMM, P317
[5]   INSULIN, GLUCAGON, AND SOMATOSTATIN IN NORMAL PHYSIOLOGY AND DIABETES-MELLITUS [J].
FELIG, P ;
WAHREN, J ;
SHERWIN, R ;
HENDLER, R .
DIABETES, 1976, 25 (12) :1091-1099
[6]  
FELIG P, 1981, PATHOPHYSIOLOGY BIOL, P542
[7]   EFFECTS OF IBOPAMINE ON SERUM PROLACTIN AND GROWTH-HORMONE LEVELS IN HYPERPROLACTINEMIC AND ACROMEGALIC SUBJECTS [J].
FERRARI, C ;
BARBIERI, C ;
CALDARA, R ;
RAMPINI, P ;
PARACCHI, A ;
BOGHEN, M ;
RAUHE, WG .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 34 (01) :74-78
[8]   STIMULATION OF GLUCAGON SECRETION BY EPINEPHRINE IN MAN [J].
GERICH, JE ;
KARAM, JH ;
FORSHAM, PH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1973, 37 (03) :479-481
[9]   EVALUATION OF SAFETY AND EFFICACY OF LEVODOPA IN PARKINSONS DISEASE AND SYNDROME - RESULTS OF A COLLABORATIVE STUDY [J].
LANGRALL, HM ;
JOSEPH, C .
NEUROLOGY, 1972, 22 (05) :3-&
[10]   EFFECT OF DOPAMINE INFUSION ON INSULIN AND GLUCAGON-SECRETION IN MAN [J].
LEBLANC, H ;
LACHELIN, GCL ;
ABUFADIL, S ;
YEN, SSC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1977, 44 (01) :196-198